Nanoparticles induced neurotoxicity DOI
Divya Bajpai Tripathy, Subhalaxmi Pradhan, Anjali Gupta

и другие.

Nanotoxicology, Год журнала: 2025, Номер unknown, С. 1 - 28

Опубликована: Апрель 16, 2025

The early development of nanotechnology has spurred major interest on the toxicity nanoparticles (NPs) due to their ability penetrate biological barriers such as BBB. This review aims at addressing how silver (AgNPs), titanium dioxide (TiO2NPs), zinc oxide (ZnONPs), iron (Fe3O4NPs), carbon NPs, Copper (Cu-NPs), silicon (SiO2 NPs) and quantum dots cause neurotoxicity. Some signaling that occur are related oxidative stress, neuroinflammation, mitochondrial dysfunction cell equilibrium, hence results in neuronal damage neurodegeneration. It is critical describe there multiple ways by NPs may be toxic based size surface, dosage, recipient's age health condition. A vitro vivo analysis provides information about potentials preventive measures including modification NP surface antioxidant treatment. underline necessity comprehensive safety assessments allow further utilization across economy.

Язык: Английский

Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives DOI Creative Commons
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary

и другие.

Frontiers in Medicine, Год журнала: 2025, Номер 12

Опубликована: Янв. 22, 2025

Parkinson’s disease is a progressive neurodegenerative that destroys substantia nigra dopaminergic neurons, causing tremors, bradykinesia, rigidity, and postural instability. Current treatment approaches primarily focus on symptom management, employing pharmacological, non-pharmacological, surgical methods. However, these treatments often result in fluctuating symptoms, side effects, progression. Here, the authors have reviewed emerging field of nanomedicine as promising path for treatment, emphasizing its potential to overcome limitations traditional therapies. Nanomedicine utilizes nanoparticles targeted drug delivery, leveraging their small size high surface area volume ratio cross blood-brain barrier deliver therapeutic agents directly affected brain regions. Various nanoparticles, including lipid-based, polymeric, metallic, carbon-based, shown treatment. Additionally, nanocarrier systems like liposomes, nanogels, dendrimers, solid lipid offer controlled sustained release agents, enhancing bioavailability reducing effects. This review provides insights into pathophysiology disease, highlighting mechanisms neurodegeneration, role alpha-synuclein, disruption pathways. It further discusses application gene therapy conjunction with interventions.

Язык: Английский

Процитировано

2

Nanoparticles induced neurotoxicity DOI
Divya Bajpai Tripathy, Subhalaxmi Pradhan, Anjali Gupta

и другие.

Nanotoxicology, Год журнала: 2025, Номер unknown, С. 1 - 28

Опубликована: Апрель 16, 2025

The early development of nanotechnology has spurred major interest on the toxicity nanoparticles (NPs) due to their ability penetrate biological barriers such as BBB. This review aims at addressing how silver (AgNPs), titanium dioxide (TiO2NPs), zinc oxide (ZnONPs), iron (Fe3O4NPs), carbon NPs, Copper (Cu-NPs), silicon (SiO2 NPs) and quantum dots cause neurotoxicity. Some signaling that occur are related oxidative stress, neuroinflammation, mitochondrial dysfunction cell equilibrium, hence results in neuronal damage neurodegeneration. It is critical describe there multiple ways by NPs may be toxic based size surface, dosage, recipient's age health condition. A vitro vivo analysis provides information about potentials preventive measures including modification NP surface antioxidant treatment. underline necessity comprehensive safety assessments allow further utilization across economy.

Язык: Английский

Процитировано

0